drugset
drugset / Trial / NCT01794923

Topical Ibuprofen for Delayed Onset Mulscle Soreness

NCT01794923 ↗

Phase 3 Completed 205 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to compare the efficacy and safety of Ibuprofen 5% Topical Gel versus placebo administered two or three times daily for the treatment of pain associated with delayed onset muscle soreness following intense eccentric exercise of the elbow flexor muscles.

Timeline

Start
2013-06-13
Primary completion
2014-03-29
Completion
2014-03-29

Outcome

Missed primary endpoint

registry Placebo Combined vs Ibuprofen Three Times Daily; p = 0.230; Least Squares (LS) Mean Difference 7.6 (95% CI -4.81 to 19.92) NCT01794923 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 5 % Topical

Indications

No indication recorded.